logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Satoshi Hokari

internal medicine
H指数:14
被引数:595

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts

尼达尼布增强PD-1阻断的抗肿瘤疗效，可能通过抑制骨髓来源抑制细胞和肿瘤相关成纤维细胞实现。

cancer immunology, immunotherapy
IF0
2026-03-050
OAAI
Ryo Suzuki; Satoshi Watanabe; Kunihiro Shono; Takaaki Masuda; Kensuke Yanai; Ryo Yamazaki; Yumi Ando; Tomoya Wakabayashi; Susumu Tanaka; Tomoki Sekiya; Kohei Kushiro; Naohiro Yanagimura; Miyuki Sato; Tomohiro Tanaka; Koichiro Nozaki; Yu Saida; Satoshi Hokari; Masashi Arita; Riuko Ohashi; Kenjiro Shima; Yosuke Kimura; Nobumasa Aoki; Yasuyoshi Ohshima; Toshiyuki Koya; Toshiaki Kikuchi
Comprehensive protein analysis to identify the proteins responsible for sarcopenia and their impact on antitumor immunotherapy in non-small cell lung cancer
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Masuda, Takaaki; Watanabe, Satoshi; Wakabayashi, Tomoya; Tanaka, Susumu; Shono, Kunihiro; Suzuki, Ryo; Sekiya, Tomoki; Yanagimura, Naohiro; Arita, Masashi; Ohtsubo, Aya; Tanaka, Tomohiro; Nozaki, Koichiro; Saida, Yu; Hokari, Satoshi; Kondo, Rie; Shima, Kenjiro; Kimura, Yosuke; Aoki, Nobumasa; Ohshima, Yasuyoshi; Koya, Toshiyuki; Sakai, Kazuko; Nishio, Kazuto; Yamazaki, Motohiko; Ishikawa, Hiroyuki; Kikuchi, Toshiaki
The impact of MRTX1133 on anti-tumor immunity in lung cancer with KRASG12D mutation
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Shono, Kunihiro; Watanabe, Satoshi; Masuda, Takaaki; Suzuki, Ryo; Wakabayashi, Tomoya; Sekiya, Tomoki; Tanaka, Susumu; Ohtsubo, Aya; Tanaka, Tomohiro; Nozaki, Koichiro; Kondo, Rie; Saida, Yu; Hokari, Satoshi; Yanagimura, Naohiro; Arita, Masashi; Ohashi, Riuko; Shima, Kenjiro; Kimura, Yosuke; Aoki, Nobumasa; Ohshima, Yasuyoshi; Koya, Toshiyuki; Kikuchi, Toshiaki
Nintedanib enhances antitumor effects of anti-PD-1 therapies through inhibition of immunosuppressive cells in tumor microenvironment
CANCER RESEARCH
IF16.6
2023-04-040
PRE
Suzuki, Ryo; Watanabe, Satoshi; Shono, Kunihiro; Masuda, Takaaki; Sekiya, Tomoki; Goto, Yuka; Fujisaki, Toshiya; Arita, Masashi; Ohtsubo, Aya; Shoji, Satoshi; Tanaka, Tomohiro; Nozaki, Koichiro; Kondo, Rie; Saida, Yu; Hokari, Satoshi; Ohashi, Riuko; Shima, Kenjiro; Kimura, Yosuke; Aoki, Nobumasa; Ohshima, Yasuyoshi; Koya, Toshiyuki; Kikuchi, Toshiaki
The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events
FRONTIERS IN ONCOLOGY
IF3.3
2021-09-2419
OAAI
Fujisaki, Toshiya; Watanabe, Satoshi; Ota, Takeshi; Kushiro, Kohei; Sato, Yusuke; Takahashi, Miho; Ohtsubo, Aya; Shoji, Satoshi; Nozaki, Koichiro; Ichikawa, Kosuke; Hokari, Satoshi; Kondo, Rie; Miyabayashi, Takao; Abe, Tetsuya; Miura, Satoru; Tanaka, Hiroshi; Okajima, Masaaki; Terada, Masaki; Matsumoto, Naoya; Ishida, Takashi; Iwashima, Akira; Sato, Kazuhiro; Yoshizawa, Hirohisa; Aoki, Nobumasa; Hayashi, Masachika; Ohshima, Yasuyoshi; Koya, Toshiyuki; Kikuchi, Toshiaki
Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease

免疫检查点抑制剂相关间质性肺病非小细胞肺癌患者的后续系统治疗

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2021-07-013
OAAI
Sato, Yusuke; Watanabe, Satoshi; Ota, Takeshi; Kushiro, Kohei; Fujisaki, Toshiya; Takahashi, Miho; Ohtsubo, Aya; Shoji, Satoshi; Nozaki, Koichiro; Ichikawa, Kosuke; Hokari, Satoshi; Kondo, Rie; Hayashi, Masachika; Ishikawa, Hiroyuki; Miyabayashi, Takao; Abe, Tetsuya; Miura, Satoru; Tanaka, Hiroshi; Okajima, Masaaki; Terada, Masaki; Ishida, Takashi; Iwashima, Akira; Sato, Kazuhiro; Yoshizawa, Hirohisa; Aoki, Nobumasa; Ohshima, Yasuyoshi; Koya, Toshiyuki; Kikuchi, Toshiaki
Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity
SCIENTIFIC REPORTS
IF3.9
2021-01-1222
OAAI
Arita, Masashi; Watanabe, Satoshi; Aoki, Nobumasa; Kuwahara, Shoji; Suzuki, Ryo; Goto, Sawako; Abe, Yuko; Takahashi, Miho; Sato, Miyuki; Hokari, Satoshi; Ohtsubo, Aya; Shoji, Satoshi; Nozaki, Koichiro; Ichikawa, Kosuke; Kondo, Rie; Hayashi, Masachika; Ohshima, Yasuyoshi; Kabasawa, Hideyuki; Hosojima, Michihiro; Koya, Toshiyuki; Saito, Akihiko; Kikuchi, Toshiaki

研究方向

暂未获取到该数据
Y
Yasuyoshi Ohshima
H 指数:12论文数:67被引数:443
T
Toshiaki Kikuchi
H 指数:45论文数:548被引数:7,926
T
Toshiyuki Koya
H 指数:28论文数:210被引数:2,748
S
Satoshi Watanabe
H 指数:40论文数:453被引数:9,096
K
Koichiro Nozaki
H 指数:12论文数:81被引数:423
R
Rie Kondo
H 指数:13论文数:72被引数:963
A
Aya Ohtsubo
H 指数:8论文数:46被引数:221
N
Nobumasa Aoki
H 指数:15论文数:70被引数:1,012
S
Satoshi Shoji
H 指数:27论文数:248被引数:2,535
M
Masashi Arita
H 指数:52论文数:559被引数:9,522